Having a Seat at the Table

Biopharmaceutical companies today are faced with significant challenges on driving R&D productivity, managing patent cliffs and increasingly more complex operating environments. At a time of such challenges, how do we in manufacturing operations ensure that we have a core seat at the table? Today, with increasingly more robust pipelines, complex processes and device technologies, along with accelerated drug development and approval timelines, it is vital that manufacturing operations is present at the decision table. More than ever, manufacturing operations is a core component to success (or failure). The question is, are we there and are we ready?